Remdesivir

Remdesivir is the active ingredient in the medication.It is available in a sterile solution for intravenous infusion (IV).The specific formulation and inactive ingredients may vary depending on the manufacturer.

Treatment of COVID19 in hospitalized adults and children (aged 12 years and older weighing at least 40 kg) with severe disease.

Treatment of COVID19 in adults and children (aged 12 years and older weighing at least 40 kg) who require supplemental oxygen or mechanical ventilation.

Cipremi 100mg Inj (Remdesivir) is an antiviral medication that inhibits the replication of the virus that causes COVID-19. It works by interfering with the virus's ability to copy its genetic material, ultimately stopping its spread within the body.

Remdesivir should be stored at room temperature (15-30°C). Protect from light and freezing.

The dosage of Remdesivir is determined by the patient's weight and clinical condition.

It is administered as a single intravenous infusion over 30 minutes or 120 minutes, depending on the formulation.

The duration of treatment is typically 5 days.

The exact dosage and infusion duration should always be prescribed by a qualified healthcare professional.

Nausea

Vomiting

Diarrhea

Decreased appetite

Elevated liver enzymes

Kidney problems (rare)

Alcohol Consumption

It is advisable to avoid alcohol consumption while taking Remdesivir as it may increase the risk of liver problems.



While Driving or operating Machinery

Remdesivir may cause dizziness, drowsiness, or confusion. Avoid driving or operating machinery until you know how this medication affects you.



Pregnant & Breastfeeding Women

Remdesivir is not recommended for use during pregnancy. It is unknown if Remdesivir passes into breast milk. Consult your doctor about the risks and benefits.



Children

Remdesivir is only approved for use in children aged 12 years and older weighing at least 40 kg.



Kidney

Remdesivir can be harmful to the kidneys. People with pre-existing kidney problems should be monitored closely.



Liver

Remdesivir can cause liver problems. People with pre-existing liver problems should be monitored closely.

https://www.fda.gov/news-events/press-announcements/fda-grants-emergency-use-authorization-remdesivir-treatment-covid-19

https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html

https://www.who.int/news-room/feature-stories/detail/who-recommends-remdesivir-for-covid-19-treatment